Athos accelerates the development of precision therapeutics for patients with immune-mediated diseases and cancer by scaling its autonomous AI analytical platform Vultr, the large, privately-held cloud computing platform, today announced that Athos Therapeutics, Inc. (“Athos”), a clinical-stage biotechnology company, has …

AI-based Small Molecule Therapeutics Pioneer Athos Therapeutics Selects Vultr for Secure AI Training in the Cloud Read more »